Furthermore, our results from in vitro cellular assays, preclinical animal models and clinical samples revealed oncogenic USP7-TAZ axis as robust biomarkers and therapeutic targets for HNSCC. The gene discussed is WWTR1; the disease is head and neck squamous cell carcinoma.